New pill for brain disorders takes first safety step
Knowledge-focused
Completed
This early-stage study tested a new oral drug called IAMA-6 in 72 healthy adults to see if it is safe and how the body processes it. The drug is being developed for neurodevelopmental disorders, but this trial did not treat any disease. Researchers monitored side effects, vital s…
Phase: PHASE1 • Sponsor: Iama Therapeutics S.r.l. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC